Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 7
2009 5
2010 9
2011 5
2012 5
2013 9
2014 4
2017 2
2018 6
2019 12
2020 16
2021 31
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year

Citations

4 articles found by citation matching

Search results

Filters applied: . Clear all
Page 1
Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40.
Rijnders M, van der Veldt AAM, de Wit R, van Leenders GJLH. Rijnders M, et al. Among authors: van der veldt aam. Eur Urol. 2019 Jun;75(6):e160-e161. doi: 10.1016/j.eururo.2019.01.039. Epub 2019 Feb 2. Eur Urol. 2019. PMID: 30723047 No abstract available.
Reply to Nelson Martinez Merizalde Balarezo, Mark Monroe Rivera, and Romina A. Tejada's Letter to the Editor re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P.J. Lolkema, Astrid A.M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017;72:411-23. Beyond the Survival Rate, Health-related Quality of Life is Important.
Rijnders M, de Wit R, Boormans JL, Lolkema MPJ, van der Veldt AAM. Rijnders M, et al. Among authors: van der veldt aam. Eur Urol. 2018 Mar;73(3):e67-e68. doi: 10.1016/j.eururo.2017.10.015. Epub 2017 Nov 1. Eur Urol. 2018. PMID: 29100815 No abstract available.
Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.
Menzer C, Menzies AM, Carlino MS, Reijers I, Groen EJ, Eigentler T, de Groot JWB, van der Veldt AAM, Johnson DB, Meiss F, Schlaak M, Schilling B, Westgeest HM, Gutzmer R, Pföhler C, Meier F, Zimmer L, Suijkerbuijk KPM, Haalck T, Thoms KM, Herbschleb K, Leichsenring J, Menzer A, Kopp-Schneider A, Long GV, Kefford R, Enk A, Blank CU, Hassel JC. Menzer C, et al. Among authors: van der veldt aam. J Clin Oncol. 2019 Nov 20;37(33):3142-3151. doi: 10.1200/JCO.19.00489. Epub 2019 Oct 3. J Clin Oncol. 2019. PMID: 31580757
Drug Effects on the Thyroid.
Angus L, Peeters RP, van der Veldt AAM. Angus L, et al. Among authors: van der veldt aam. N Engl J Med. 2019 Nov 14;381(20):1980. doi: 10.1056/NEJMc1912672. N Engl J Med. 2019. PMID: 31722168 No abstract available.
PD-L1 Antibody Comparison in Urothelial Carcinoma.
Rijnders M, van der Veldt AAM, Zuiverloon TCM, Grünberg K, Thunnissen E, de Wit R, van Leenders GJLH. Rijnders M, et al. Among authors: van der veldt aam. Eur Urol. 2019 Mar;75(3):538-540. doi: 10.1016/j.eururo.2018.11.002. Epub 2018 Nov 27. Eur Urol. 2019. PMID: 30497882 No abstract available.
An Overview of Liver Directed Locoregional Therapies.
Höppener DJ, Grünhagen DJ, Eggermont AMM, van der Veldt AAM, Verhoef C. Höppener DJ, et al. Among authors: van der veldt aam. Surg Oncol Clin N Am. 2021 Jan;30(1):103-123. doi: 10.1016/j.soc.2020.09.001. Surg Oncol Clin N Am. 2021. PMID: 33220800 Free article. Review.
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study.
de Joode K, Dumoulin DW, Tol J, Westgeest HM, Beerepoot LV, van den Berkmortel FWPJ, Mutsaers PGNJ, van Diemen NGJ, Visser OJ, Oomen-de Hoop E, Bloemendal HJ, van Laarhoven HWM, Hendriks LEL, Haanen JBAG, de Vries EGE, Dingemans AC, van der Veldt AAM; DOCC Investigators. de Joode K, et al. Among authors: van der veldt aam. Eur J Cancer. 2020 Dec;141:171-184. doi: 10.1016/j.ejca.2020.09.027. Epub 2020 Oct 7. Eur J Cancer. 2020. PMID: 33161241 Free PMC article.
In vivo imaging as a pharmacodynamic marker.
van der Veldt AA, Lammertsma AA. van der Veldt AA, et al. Clin Cancer Res. 2014 May 15;20(10):2569-77. doi: 10.1158/1078-0432.CCR-13-2666. Clin Cancer Res. 2014. PMID: 24831279 Free article. Review.
Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment.
Hurkmans DP, Verhoeven JGHP, de Leur K, Boer K, Joosse A, Baan CC, von der Thüsen JH, van Schaik RHN, Mathijssen RHJ, van der Veldt AAM, Hesselink DA. Hurkmans DP, et al. Among authors: van der veldt aam. J Immunother Cancer. 2019 Jul 12;7(1):182. doi: 10.1186/s40425-019-0653-6. J Immunother Cancer. 2019. PMID: 31300068 Free PMC article.
107 results